In this issue:
Japanese guidelines support prophylactic G-CSF during cabazitaxel treatment
Promising novel therapeutic agents for prostate cancer
Are guidelines on prostate cancer screening in older males followed?
Prostate cancer contouring improved by AI
Prostate cancer trials enrolling in Australia
Changes to PBS authorities
New PBS listings
Updates to TGA guidance
Discontinuation of COVID telehealth rebates and exemptions
Upcoming PBAC agenda
Talazoparib approved for prostate cancer in Japan
Trial of the oral polymerase theta helicase inhibitor MOMA-313 has commenced
‘The Long Run’ is on in September
Urology Care Foundation patient resources
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)